Table 2.
Pre-pandemic to 1-year peri-pandemic prevalence of positive screens for MDD, GAD, and PTSD among U.S. military veterans
| Pre-pandemic N (weighted %) |
1-Year peri-pandemic N (weighted %) |
Test of difference | p | |
|---|---|---|---|---|
| MDD | 198 (7.6) | 225 (8.6) | 3.31 | 0.07 |
| Age 18–44 | 31 (18.8) | 33 (21.6) | 1.41 | 0.24 |
| Age 45–64 | 97 (9.7) | 102 (10.5) | 0.57 | 0.45 |
| Age 65+ | 197 (3.4) | 219 (4.0) | 1.16 | 0.28 |
| GAD | 161 (7.1) | 241 (9.4) | 18.92 | <0.001 |
| Age 18–44 | 35 (21.7) | 39 (23.0) | 0.28 | 0.60 |
| Age 45–64 | 76 (8.2) | 123 (13.5) | 22.26 | <0.001 |
| Age 65+ | 49 (2.5) | 74 (3.3) | 1.41 | 0.24 |
| PTSD | 140 (4.8) | 113 (4.1) | 2.16 | 0.14 |
| Age 18–44 | 12 (16.6) | 16 (13.3) | 1.16 | 0.28 |
| Age 45–64 | 59 (13.3) | 64 (11.8) | 0.65 | 0.42 |
| Age 65+ | 31 (3.6) | 30 (3.5) | 0.00 | 1.00 |
MDD, major depressive disorder; GAD, generalized anxiety disorder; PTSD, posttraumatic stress disorder.
Statistically significant p values (p < 0.05) are bolded.